The All India Institute Of Medical Science in New Delhi recently unveiled its new AI solution that assists with the early detection of cancer. Developed with the Centre for Development of Advanced Computing, Pune under the Ministry…
Continue Reading
Radformation and Icon Group have forged a transformative partnership to redefine cancer care through cutting-edge software solutions and streamlined workflows. This collaboration combines Radformation’s expertise in radiation oncology software with Icon Group’s global leadership…
Continue Reading
London-based telehealth company QuestPrehab has won a world-first, pioneering contract to provide digital prehabilitation (‘prehab’) services to China.In an exclusive partnership with international consulting firm IHSN Healthcare, QuestPrehab will supply prehab services to patients…
Continue Reading
The partnership between ACRO, ACR, ASTRO, and ASCO signifies a pivotal effort to address the critical challenges posed by Medicare payment cuts in radiation oncology. As leaders in the field, these organizations pool their…
Continue Reading
What You Should Know: – PathAI, a pioneer in AI-powered pathology, announced a significant expansion of its PathExplore platform, adding six new oncology indications to its arsenal. – The expansion doubles the platform’s reach,…
Continue Reading
New adjunct specialty facilities in India’s leading health institutions are advancing precision medicine in the country through AI. The Apollo Cancer Centre (ACC) in Bengaluru has recently opened what could be the country’s first Precision…
Continue Reading
The Anticipated Acquisition Aligns to GE HealthCare’s Precision Care Strategy with the Goal of Strengthening the Company’s Digital Solutions Across Care Pathways
MIM Software Provides AI-Enabled Image Analysis and Workflow Tools Across Multiple Care Areas,…
Elephas, an oncology-focused diagnostics platform, announced it secured $55 million in Series C funding, bringing its total raise to $116.5 million. Venture Investors Health Fund and the State of Wisconsin Investment Board (SWIB) led the…
Continue Reading
What You Should Know:
– Invitae (NYSE: NVTA), a medical genetics company, announced the completion of its sale of certain reproductive health assets, including carrier screening and non-invasive prenatal screening (NIPS), to Natera (NASDAQ: NTRA).
–…
Continue Reading
CMS’s new national payment rate and unique reimbursement codes signal a transformative shift in radiotherapy reimbursement, removing barriers to the clinical adoption of RefleXion’s SCINTIX biology-guided radiotherapy. The breakthrough approach, utilizing emissions from cancer…
Continue Reading
